PAXMAN AB
Research PAXMAN AB (B0F) on Bullrun: market cap EUR 99.38M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerB0F
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 99.38M
- Financial periodQ4 2025
- RevenueEUR 84.42M
- Net income-EUR 8.76M
- Free cash flow-EUR 2.26M
- Gross margin66.6%
Valuation Snapshot
latest market cap is EUR 99.38M.
About PAXMAN AB
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.
Frequently asked questions
What is PAXMAN AB's market cap?
PAXMAN AB's market capitalization is EUR 99.38M.
What does PAXMAN AB do?
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia.